marketcaparena
Search

    CGON

    CG Oncology, Inc.

    Company overview

    Market capitalization
    $6.17B
    Employees
    142
    Latest publication
    2026-09-29
    About CG Oncology, Inc.

    CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue1,157,000USD1,083,000USD2,322,000USD1,666,000USD0USD52,000USD456,000USD43,000USD
    Research Development54,657,000USD43,730,000USD29,959,000USD27,884,000USD31,331,000USD27,467,000USD26,800,000USD19,622,000USD
    Selling General Administrative28,976,000USD20,780,000USD17,994,000USD23,334,000USD17,410,000USD14,789,000USD11,705,000USD8,716,000USD
    General And Administrative Expenses28,976,000USD———————
    Total Operating Expenses83,633,000USD64,510,000USD48,108,000USD51,218,000USD48,741,000USD42,256,000USD38,505,000USD28,338,000USD
    Operating Income-86,401,000USD-66,389,000USD-48,700,000USD-51,129,000USD-48,741,000USD-42,204,000USD-38,049,000USD-28,295,000USD
    Total Other Income Expense Net7,345,000USD6,186,999USD7,391,000USD7,321,000USD7,315,000USD7,752,000USD6,251,000USD7,890,000USD
    Interest Income7,329,000USD6,288,000USD7,444,000USD7,421,000USD7,319,000USD7,747,000USD6,245,000USD7,892,000USD
    Net Income-79,056,000USD-60,202,000USD-41,309,000USD-43,808,000USD-41,426,000USD-34,452,000USD-31,798,000USD-20,405,000USD
    Cost Of Revenue3,925,000USD2,962,000USD2,914,000USD1,577,000USD156,000USD0USD—0USD
    Gross Profit—-1,879,000USD-592,000USD89,000USD-156,000USD52,000USD456,000USD43,000USD
    Net Interest Income—6,288,000USD7,444,000USD7,421,000USD7,319,000USD7,747,000USD6,245,000USD7,892,000USD
    Income Before Tax—-60,202,000USD-41,309,000USD-43,808,000USD-41,426,000USD-34,452,000USD-31,798,000USD-20,405,000USD
    Net Income From Continuing Ops—-60,202,000USD-41,309,000USD-43,808,000USD-41,426,000USD-34,452,000USD-31,798,000USD-20,405,000USD
    Ebit—-66,388,999USD-41,309,000USD-43,808,000USD-48,741,000USD-42,204,000USD-38,017,000USD-28,295,000USD
    Ebitda—-65,547,999USD-40,460,000USD-43,392,000USD-48,585,000USD-42,180,000USD-38,049,000USD-28,274,000USD
    Depreciation And Amortization—841,000USD849,000USD416,000USD156,000USD24,000USD-32,000USD21,000USD
    Reconciled Depreciation—841,000USD849,000USD416,000USD156,000USD24,000USD0USD21,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Revenue4,040,000USD1,139,000USD204,000USD191,000USD10,358,000USD
    Cost Of Revenue4,647,000USD32,000USD17,000USD15,000USD10,000USD
    Gross Profit-607,000USD1,139,000USD204,000USD176,000USD10,348,000USD
    Research Development116,641,000USD82,102,000USD45,752,000USD29,029,000USD18,319,000USD
    Selling General Administrative73,526,000USD33,703,000USD9,901,000USD6,408,000USD4,645,000USD
    Total Operating Expenses190,167,000USD115,805,000USD55,653,000USD35,422,000USD22,954,000USD
    Operating Income-190,774,000USD-114,666,000USD-55,449,000USD-35,246,000USD-12,606,000USD
    Interest Income29,931,000USD26,624,000USD6,904,000USD——
    Net Interest Income29,931,000USD26,624,000USD6,904,000USD-1,000USD-451,000USD
    Income Before Tax-160,995,000USD-88,039,000USD-48,607,000USD-35,443,000USD-12,839,000USD
    Net Income-160,995,000USD-88,039,000USD-48,607,000USD-35,443,000USD-12,839,000USD
    Net Income From Continuing Ops-160,995,000USD-88,039,000USD-48,607,000USD-35,443,000USD-12,839,000USD
    Ebit-160,995,000USD-114,666,000USD-55,449,000USD-35,246,000USD-12,388,000USD
    Ebitda-159,550,000USD-114,634,000USD-55,432,000USD-35,231,000USD-12,378,000USD
    Depreciation And Amortization1,445,000USD32,000USD17,000USD15,000USD10,000USD
    Reconciled Depreciation1,445,000USD32,000USD17,000USD15,000USD10,000USD
    Total Other Income Expense Net29,779,000USD26,627,000USD6,842,000USD-197,000USD-233,000USD
    Selling And Marketing Expenses——17,000USD15,000USD10,000USD
    Interest Expense——6,904,000USD1,000USD451,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,085,655,000USD1,135,262,000USD791,592,000USD729,913,000USD701,445,000USD728,181,000USD754,797,000USD552,471,000USD
    Cash And Equivalents19,636,000USD———————
    Cash And Short Term Investments1,028,278,000USD1,076,242,000USD742,155,000USD680,263,000USD661,052,000USD688,434,000USD741,998,000USD540,710,000USD
    Short Term Investments1,008,642,000USD1,042,542,000USD709,665,000USD635,118,000USD646,428,000USD646,962,000USD484,930,000USD497,299,000USD
    Total Current Assets1,049,647,000USD1,102,143,000USD759,475,000USD695,790,000USD673,030,000USD701,192,000USD754,210,000USD552,080,000USD
    Other Current Assets19,949,000USD23,133,000USD15,067,000USD13,511,000USD11,416,000USD12,413,000USD11,431,000USD11,233,000USD
    Other Non Current Assets4,729,000USD———————
    Total Liabilities56,537,000USD———————
    Total Current Liabilities47,240,000USD35,216,000USD30,836,000USD30,528,000USD30,381,000USD22,642,000USD21,368,000USD15,630,000USD
    Other Non Current Liabilities1,156,000USD———————
    Total Stockholder Equity1,029,118,000USD1,091,779,000USD752,602,000USD687,643,000USD670,358,000USD704,758,000USD733,377,000USD536,770,000USD
    Total Equity Including Noncontrolling Interest1,029,118,000USD———————
    Long Term Debt3,000,000USD3,000,000USD3,000,000USD3,000,000USD————
    Inventory1,003,000USD1,493,000USD1,565,000USD1,501,000USD——0USD—
    Property Plant Equipment Net20,437,000USD19,586,000USD19,567,000USD19,532,000USD1,218,000USD1,297,000USD493,000USD338,000USD
    Goodwill10,297,000USD———————
    Accounts Payable12,727,000USD8,236,000USD5,714,000USD9,193,000USD7,125,000USD6,731,000USD6,517,000USD4,076,000USD
    Short Term Debt985,000USD1,066,000USD915,000USD912,000USD288,000USD255,000USD186,000USD225,000USD
    Common Stock9,000USD9,000USD8,000USD8,000USD8,000USD8,000USD8,000USD7,000USD
    Retained Earnings-518,234,000USD-439,178,000USD-378,976,000USD-337,667,000USD-293,859,000USD-252,433,000USD-217,981,000USD-186,183,000USD
    Intangible Assets—560,000USD575,000USD1,672,000USD————
    Total Liab—43,483,000USD38,990,000USD42,270,000USD31,087,000USD23,423,000USD21,420,000USD15,701,000USD
    Other Current Liab—25,914,000USD24,207,000USD20,164,000USD22,968,000USD15,656,000USD14,665,000USD11,329,000USD
    Capital Stock—9,000USD8,000USD8,000USD8,000USD8,000USD8,000USD7,000USD
    Good Will—10,297,000USD10,297,000USD12,805,000USD——0USD—
    Cash—33,700,000USD32,490,000USD45,145,000USD14,624,000USD41,472,000USD257,068,000USD43,411,000USD
    Net Debt—-26,125,000USD-25,469,000USD-37,904,000USD-13,630,000USD-40,436,000USD-256,830,000USD-43,115,000USD
    Short Long Term Debt Total—7,575,000USD7,021,000USD7,241,000USD994,000USD1,036,000USD238,000USD296,000USD
    Net Receivables—1,275,000USD688,000USD515,000USD562,000USD345,000USD781,000USD137,000USD
    Property Plant Equipment Gross—21,880,000USD21,041,000USD20,155,000USD1,218,000USD1,297,000USD493,000USD338,000USD
    Common Stock Shares Outstanding—84,518,512shares77,303,440shares76,729,726shares76,226,829shares76,187,621shares64,820,235shares67,143,744shares
    Non Current Assets Total—33,119,000USD32,117,000USD34,123,000USD28,415,000USD26,989,000USD587,000USD391,000USD
    Non Current Liabilities Total—8,267,000USD8,154,000USD11,742,000USD706,000USD781,000USD52,000USD71,000USD
    Non Current Liabilities Other—1,451,000USD1,741,000USD3,804,000USD————
    Non Currrent Assets Other—2,676,000USD1,678,000USD114,000USD27,197,000USD25,692,000USD94,000USD53,000USD
    Net Working Capital—1,066,927,000USD728,639,000USD665,262,000USD642,649,000USD678,550,000USD732,842,000USD536,450,000USD
    Unclassified Non Current Liabilities—3,816,000USD3,413,000USD4,938,000USD————
    Unclassified Equity—1,530,939,000USD1,131,562,000USD1,025,294,000USD964,201,000USD957,175,000USD951,342,000USD722,939,000USD
    Current Deferred Revenue———259,000USD————
    Accumulated Other Comprehensive Income————0USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Assets791,592,000USD754,797,000USD199,301,000USD147,747,000USD58,692,000USD
    Intangible Assets575,000USD————
    Other Current Assets15,067,000USD11,431,000USD6,358,000USD3,424,000USD4,798,000USD
    Total Liab38,990,000USD21,420,000USD14,511,000USD22,570,000USD18,440,000USD
    Total Stockholder Equity752,602,000USD733,377,000USD184,790,000USD125,177,000USD40,252,000USD
    Other Current Liab24,207,000USD14,665,000USD10,226,000USD5,289,000USD1,957,000USD
    Common Stock8,000USD8,000USD—4,000USD3,000USD
    Capital Stock8,000USD8,000USD307,890,000USD202,870,000USD82,870,000USD
    Retained Earnings-378,976,000USD-217,981,000USD-129,942,000USD-81,335,000USD-45,892,000USD
    Good Will10,297,000USD0USD———
    Cash32,490,000USD257,068,000USD8,266,000USD88,143,000USD53,607,000USD
    Cash And Short Term Investments742,155,000USD741,998,000USD187,674,000USD143,481,000USD53,607,000USD
    Total Current Assets759,475,000USD754,210,000USD194,124,000USD147,208,000USD58,407,000USD
    Total Current Liabilities30,836,000USD21,368,000USD14,254,000USD15,429,000USD5,975,000USD
    Net Debt-25,469,000USD-256,830,000USD-7,236,000USD-72,199,000USD-38,478,000USD
    Short Term Debt915,000USD186,000USD786,000USD9,155,000USD3,015,000USD
    Short Long Term Debt Total7,021,000USD238,000USD1,030,000USD15,944,000USD15,129,000USD
    Long Term Debt3,000,000USD——6,532,000USD12,064,000USD
    Short Term Investments709,665,000USD484,930,000USD179,408,000USD55,338,000USD0USD
    Net Receivables688,000USD781,000USD92,000USD303,000USD2,000USD
    Inventory1,565,000USD0USD———
    Accounts Payable5,714,000USD6,517,000USD3,242,000USD985,000USD1,003,000USD
    Property Plant Equipment Net19,567,000USD493,000USD491,000USD506,000USD200,000USD
    Property Plant Equipment Gross21,041,000USD493,000USD491,000USD506,000USD200,000USD
    Common Stock Shares Outstanding77,303,440shares62,496,725shares66,636,252shares66,636,252shares66,636,252shares
    Non Current Assets Total32,117,000USD587,000USD5,177,000USD539,000USD285,000USD
    Non Current Liabilities Total8,154,000USD52,000USD257,000USD7,141,000USD12,465,000USD
    Non Current Liabilities Other1,741,000USD—13,000USD352,000USD351,000USD
    Non Currrent Assets Other1,678,000USD94,000USD4,686,000USD33,000USD85,000USD
    Net Working Capital728,639,000USD732,842,000USD179,870,000USD131,779,000USD52,432,000USD
    Unclassified Non Current Liabilities3,413,000USD————
    Unclassified Equity1,131,562,000USD951,342,000USD6,842,000USD3,638,000USD3,274,000USD
    Other Assets——1USD——
    Short Long Term Debt———8,966,000USD2,943,000USD
    Unclassified Current Liabilities———-8,966,000USD-2,943,002USD
    Current Deferred Revenue————2USD
    Accumulated Other Comprehensive Income————-3,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation1,691,000USD
    Stock Based Compensation20,808,000USD
    Other Non Cash Items-92,000USD
    Change To Account Receivables271,000USD
    Change To Inventory562,000USD
    Change To Liabilities15,704,000USD
    Change In Working Capital-87,000USD
    Operating Cash Flow-103,357,000USD
    Capital Expenditures-772,000USD
    Net Investments-303,645,000USD
    Investing Cash Flow-304,417,000USD
    Net Common Stock Issuance-194,000USD
    Unclassified Financing Cash Flow395,114,000USD
    Financing Cash Flow394,920,000USD
    Change In Cash-12,854,000USD
    End Cash Flow19,636,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-60,202,000USD-41,309,000USD-43,808,000USD-41,426,000USD-34,452,000USD-31,798,000USD-20,405,000USD-18,904,000USD
    Depreciation841,000USD849,000USD416,000USD156,000USD24,000USD0USD21,000USD7,000USD
    Stock Based Compensation6,474,000USD7,187,000USD7,331,000USD7,007,000USD5,151,000USD4,990,000USD2,649,000USD2,246,000USD
    Other Non Cash Items8,197,000USD1,040,000USD40,000USD-2,359,000USD-469,000USD1,250,000USD-1,586,000USD-2,476,000USD
    Change To Account Receivables-587,000USD-301,000USD-238,000USD-217,000USD436,000USD-644,000USD45,000USD-90,000USD
    Change To Inventory72,000USD-64,000USD-380,000USD—0USD———
    Change In Working Capital-5,779,000USD-3,983,000USD-2,873,000USD8,663,000USD469,000USD4,896,000USD3,402,000USD3,007,000USD
    Total Cash From Operating Activities-56,943,000USD-36,216,000USD-38,894,000USD-27,959,000USD-29,277,000USD-20,662,000USD-15,919,000USD-16,120,000USD
    Capital Expenditures-304,000USD-7,000USD-97,000USD-14,000USD-16,000USD-209,000USD-1,000USD-14,000USD
    Free Cash Flow-57,247,000USD-36,223,000USD-38,991,000USD-27,973,000USD-29,293,000USD-20,871,000USD-15,918,000USD-16,134,000USD
    Investments-334,541,000USD-75,498,000USD15,045,000USD1,407,000USD-186,769,000USD10,905,000USD32,005,000USD-36,230,000USD
    Total Cashflows From Investing Activities-334,845,000USD-75,505,000USD15,045,000USD1,407,000USD-186,769,000USD10,905,000USD32,005,000USD-36,230,000USD
    Total Cash From Financing Activities392,998,000USD99,066,000USD54,370,000USD-296,000USD450,000USD223,414,000USD2,167,000USD40,000USD
    Issuance Of Capital Stock391,550,000USD98,449,000USD49,001,000USD0USD0USD223,059,000USD0USD0USD
    Change In Cash1,210,000USD-12,655,000USD30,521,000USD-26,848,000USD-215,596,000USD213,657,000USD18,253,000USD-52,310,000USD
    Begin Period Cash Flow32,490,000USD45,145,000USD14,624,000USD41,472,000USD257,068,000USD43,411,000USD25,158,000USD77,468,000USD
    End Period Cash Flow33,700,000USD32,490,000USD45,145,000USD14,624,000USD41,472,000USD257,068,000USD43,411,000USD25,158,000USD
    Other Cashflows From Financing Activities-174,000USD99,066,000USD5,369,000USD-296,000USD450,000USD-365,000USD2,167,000USD40,000USD
    Unclassified Operating Cash Flow-6,474,000USD———————
    Net Borrowings—0USD0USD0USD0USD0USD0USD—
    Unclassified Financing Cash Flow—-98,449,000USD——————
    Other Cashflows From Investing Activities——26,000,000USD-1,000,000USD-25,000,000USD———
    Unclassified Investing Cash Flow——-25,903,000USD1,014,000USD25,016,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Net Income-160,995,000USD-88,039,000USD-48,607,000USD-35,443,000USD-12,839,000USD
    Depreciation1,445,000USD32,000USD17,000USD15,000USD10,000USD
    Stock Based Compensation26,676,000USD11,402,000USD1,528,000USD676,000USD1,112,000USD
    Other Non Cash Items-1,748,000USD-5,014,000USD-2,056,000USD509,000USD30,000USD
    Change To Account Receivables-320,000USD-689,000USD0USD——
    Change To Inventory-444,000USD0USD0USD——
    Change In Working Capital2,276,000USD2,906,000USD3,439,000USD4,439,000USD-1,967,000USD
    Total Cash From Operating Activities-132,346,000USD-78,713,000USD-45,679,000USD-29,804,000USD-13,654,000USD
    Capital Expenditures-134,000USD-234,000USD0USD-14,000USD-97,000USD
    Free Cash Flow-132,480,000USD-78,947,000USD-45,679,000USD-29,818,000USD-13,751,000USD
    Investments-223,721,000USD-300,764,000USD-121,195,000USD-55,352,000USD-97,000USD
    Total Cashflows From Investing Activities-245,822,000USD-300,764,000USD-121,195,000USD-55,352,000USD-97,000USD
    Net Borrowings0USD-365,000USD-16,291,000USD0USD15,201,000USD
    Total Cash From Financing Activities153,590,000USD628,279,000USD86,997,000USD119,692,000USD15,446,000USD
    Issuance Of Capital Stock147,450,000USD629,469,000USD104,627,000USD119,526,000USD0USD
    Change In Cash-224,578,000USD248,802,000USD-79,877,000USD34,536,000USD1,695,000USD
    Begin Period Cash Flow257,068,000USD8,266,000USD88,143,000USD53,607,000USD51,912,000USD
    End Period Cash Flow32,490,000USD257,068,000USD8,266,000USD88,143,000USD53,607,000USD
    Other Cashflows From Financing Activities153,590,000USD-825,000USD103,288,000USD119,526,000USD-97,000USD
    Unclassified Investing Cash Flow-21,967,000USD——55,352,000USD—
    Unclassified Financing Cash Flow-147,450,000USD—-104,627,000USD-119,360,000USD—
    Other Cashflows From Investing Activities———-55,338,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductCommercial And Development Revenue1,147,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLicense And Collaboration Revenue10,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCommercial And Development Revenue1,069,000USD0001193125-26-214669
    Q1 2026Quarterly · 2026-03-31ProductLicense And Collaboration Revenue14,000USD0001193125-26-214669
    FY 2025Yearly · 2025-12-31ProductCommercial And Development Revenue3,234,000USD0001193125-26-079498
    FY 2025Yearly · 2025-12-31ProductLicense And Collaboration Revenue806,000USD0001193125-26-079498
    Q3 2025Quarterly · 2025-09-30ProductCommercial And Development Revenue1,508,000USD0001193125-25-283000
    Q3 2025Quarterly · 2025-09-30ProductLicense And Collaboration Revenue158,000USD0001193125-25-283000
    Q1 2025Quarterly · 2025-03-31ProductCommercial And Development Revenue0USD0001193125-26-214669
    Q1 2025Quarterly · 2025-03-31ProductLicense And Collaboration Revenue52,000USD0001193125-26-214669
    FY 2024Yearly · 2024-12-31ProductCommercial And Development Revenue0USD0001193125-26-079498
    FY 2024Yearly · 2024-12-31ProductLicense And Collaboration Revenue1,139,000USD0001193125-26-079498
    Q3 2024Quarterly · 2024-09-30ProductCommercial And Development Revenue0USD0001193125-25-283000
    Q3 2024Quarterly · 2024-09-30ProductLicense And Collaboration Revenue43,000USD0001193125-25-283000
    FY 2023Yearly · 2023-12-31ProductCommercial And Development Revenue0USD0001193125-26-079498
    FY 2023Yearly · 2023-12-31ProductLicense And Collaboration Revenue204,000USD0001193125-26-079498

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.